The litigation is related to high-frequency spinal cord stimulation technology for pain relief.
Boston Scientific will pay Nevro $85 million, and in return, will receive a license to practice paresthesia-free therapy at frequencies below 1,500Hz, according to an Aug. 1 press release.
Boston Scientific will also give Nevro a license to use features from its family of patents.
This settlement concludes all ongoing litigation between the two parties.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
